CHO Plus, Inc. ( a leading developer of biopharmaceutical manufacturing technology, announced that U.S. Patent No. 12,252,713 was issued by the United States Patent and Trademark Office. The patent ...

A vaccine against norovirus, the dreaded “winter vomiting bug”, could be closer than you think: early clinical trials have ...

In a potentially major breakthrough for regenerative medicine, scientists at MIT have developed a way to convert skin cells ...

After scoring tax abatements for a $100 million investment in The Woodlands last year, the company appears to be close to beginning the project.

Apriori Bio has become the latest Flagship Pioneering-backed biotech to shed staff, cutting 15 workers to leave 21 still ...

Development strategies designed to reduce the unknowns so that cell and gene therapy innovators can develop robust processes ...

The global viral vectors for non-human primates market was valued at USD 145.8 Mn in 2023 and is projected to grow at a CAGR ...

Strasbourg (France), March 11, 2025, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today ...

John Roehrig died March 8 after a battle with ALS. During his career, he was on the front lines of the U.S. response to West Nile virus.

Funds will help the companies create a platform for the manufacturing and characterization of AAV-based gene therapy vectors.